Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin in Fontan patients
NCT02966002Phase 4Terminated
- Sponsor
- University of Michigan
- Start
- Apr 2016
- Primary completion
- May 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label trial of aspirin in inflammation and hypercholesterolemia, sponsored by University of Michigan. Primary endpoints: Change in Total Cholesterol at 8 weeks and Change in High-Density Lipoprotein Cholesterol at 8 weeks. Started Apr 2016; status: terminated.
02
Drugs
aspirin
03
Conditions
inflammationhypercholesterolemia
Beyond the preview
Go deeper on NCT02966002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02966002.